您的位置: 专家智库 > >

国家自然科学基金(81373823)

作品数:2 被引量:50H指数:2
相关作者:焦阳高铸烨李思铭徐浩更多>>
相关机构:北京中医药大学中国中医科学院西苑医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生

主题

  • 1篇丹参
  • 1篇丹参酮
  • 1篇丹参酮IIA...
  • 1篇心病
  • 1篇心血管
  • 1篇血管
  • 1篇炎症
  • 1篇炎症因子
  • 1篇医药
  • 1篇中国医药
  • 1篇注射液
  • 1篇磺酸
  • 1篇磺酸钠
  • 1篇磺酸钠注射液
  • 1篇冠心病
  • 1篇PATIEN...
  • 1篇SYNDRO...
  • 1篇CHINES...
  • 1篇COR

机构

  • 1篇北京中医药大...
  • 1篇中国中医科学...

作者

  • 1篇徐浩
  • 1篇李思铭
  • 1篇高铸烨
  • 1篇焦阳

传媒

  • 1篇Chines...
  • 1篇世界中医药

年份

  • 1篇2014
  • 1篇2013
2 条 记 录,以下是 1-2
排序方式:
丹参酮ⅡA磺酸钠注射液与冠心病炎症因子的研究进展被引量:36
2013年
大量的基础和临床研究均证实炎症反应在动脉粥样硬化的发生发展过程中起着重要作用。炎症反应促使冠状动脉内不稳定斑块的形成和破裂,在此基础上导致的血栓形成,是大多数急性冠脉综合征(ACS)发生的主要原因。丹参酮IIA磺酸钠(sodium tanshinone IIA sulfonate,STS)具有改善血液循环、抑制炎症反应等作用,主要用于冠心病的治疗。本文对STS与冠心病相关炎症因子C反应蛋白、同型半胱氨酸、肿瘤坏死因子-α、人白细胞分化抗原40、纤维蛋白原、白细胞介素-6、基质金属蛋白酶、核因子-кB的相关性进行综述,以期为探索STS对冠心病炎症因子的具体作用环节提供参考。
焦阳李思铭高铸烨徐浩
关键词:冠心病丹参酮IIA磺酸钠注射液炎症因子
Multifactor Dimensionality Reduction Analysis of the Correlation of Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease被引量:14
2014年
Objective:To analyze the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease(CHD).Methods:This prospective cohort study investigated and collected the clinical information of patients with stable CHD and observed the syndrome type at the baseline and6-month at follow-up,as well as the cardiovascular events during the 6-month and 12-month follow-up.The patients were divided into the event group and the non-event group.The interaction and the impact of syndrome evolvement on cardiovascular events were examined through multifactor dimensionality reduction(MDR)analysis and the results were verified by Chi-square test.Results:Totally 1,333 of 1,503 stable CHD patients enrolled met the inclusion criteria of MDR analysis.Among them,959(71.9%)cases were males and 374(28.1%)cases were females.Thirty seven cases had cardiovascular events during 6 to 12 months after the study began.The results of the MDR analysis and verification using Chi-square test showed that the development of cardiovascular events was positively correlated with interaction between blood stasis and toxic syndrome at the baseline,blood stasis at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the base line and blood stasis at the 6-month follow-up,qi deficiency and blood stasis at the 6-month follow-up(P<0.05for all).Conclusions:Blood stasis,toxic syndrome and qi deficiency are important factors of stable CHD.There are positive correlation between cardiovascular events and syndrome evolution from blood stasis to qi deficiency,from toxic syndrome to qi deficiency and from toxic syndrome to blood stasis,indicating the pathogenesis of toxin consuming qi,toxin leading to blood-stasis in stable CHD patients prone to recurrent cardiovascular events.
焦阳李四维尚青华付长庚高铸烨徐浩史大卓陈可冀
关键词:心血管中国医药
共1页<1>
聚类工具0